Equity Overview
Price & Market Data
Price: $0.0401
Daily Change: $0.00 / 0.00%
Daily Range: $0.0401 - $0.0401
Market Cap: $3,786,332
Daily Volume: 1,010
Performance Metrics
1 Week: 0.13%
1 Month: -8.77%
3 Months: -52.88%
6 Months: -39.73%
1 Year: -55.50%
YTD: -8.21%
Details
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of products for the aging population. Its lead drug candidate is Fexapotide Triflutate (NX-1207) for the treatment of benign prostatic hyperplasia and low-grade localized prostate cancer, as well as hepatocellular carcinoma. The company also offers NicAlert, a test for determining smoking status; and TobacAlert, a test for detecting second-hand smoke exposure. In addition, it develops drugs for the treatment and prevention of Alzheimer's disease. Nymox Pharmaceutical Corporation was founded in 1989 and is headquartered in Nassau, Bahamas.